Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Melonfrost

Explore full profile

Innovative genome rewiring for creating disease-treating viruses, plastic-eating bacteria, and multi-functional yeast

New York City, United StatesFounded 2019Biotech & Life Sciences
Valuation $25–50M Last recorded · 2023
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Melonfrost and the history behind them.

About Melonfrost

Melonfrost is an innovative biotechnology startup that specializes in creating custom organisms to solve some of the world's most pressing problems. The company operates at the intersection of machine learning and evolutionary biology, using advanced techniques to rewire entire genomes in real-time. This allows Melonfrost to develop unique solutions such as viruses that can treat diseases, bacteria that can break down plastic, and yeast that can produce food, fuel, and pharmaceuticals.

The primary clients of Melonfrost are businesses and organizations in the healthcare, environmental, and industrial sectors. These clients are looking for cutting-edge biotechnological solutions to improve their products and processes. For example, pharmaceutical companies might seek Melonfrost's expertise to develop new treatments, while environmental organizations might use their bacteria to tackle plastic pollution.

Melonfrost operates in the rapidly growing synthetic biology market, which involves designing and constructing new biological parts, devices, and systems. The company's business model is based on providing tailored biotechnological solutions to its clients. They generate revenue through service contracts, licensing agreements, and potentially by selling proprietary organisms and technologies.

In summary, Melonfrost is a pioneering company that leverages the power of machine learning and evolutionary biology to create organisms with specific, beneficial traits. Their work has the potential to revolutionize industries by offering sustainable and innovative solutions to complex problems.

Source: Dealroom company data

At a glance

Founded
2019
Headquarters
New York City, United States
Sector
Biotech & Life Sciences

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Melonfrost on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Melonfrost on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.